Advanced Wound Care Market Size, Share, Opportunities, And Trends By Product Type (Dressings (Foam Dressings, Hydrocolloid Dressings, Alginate Dressings, Film Dressings, Hydrogel Dressings, Collagen Dressings, Others), Wound Therapy Devices (Negative Pressure Wound Therapy (Npwt) Devices, Oxygen And Hyperbaric Oxygen Equipment, Electrical Stimulation Devices, Ultrasound Therapy Devices, Others), By Wound Type (Diabetic Ulcers, Pressure Ulcers, Venous Ulcers, Surgical Wounds, Burns, Others), By End-User (Hospitals And Clinics, Home Care Settings, Long-Term Care Centers, Ambulatory Surgical Centers, Others), And By Geography - Forecasts From 2023 To 2028

The advanced wound care market is projected to grow at a CAGR of 4.52% over the forecast period, increasing from US$3.133 billion in 2021 to a total market size of US$4.27 billion by 2028.

The advanced wound care refers to the treatment of difficult and chronic wounds. When compared to standard wound dressings, advanced wound care comprises novel materials and therapies that promote quicker and more efficient wound healing. The expansion of this market is being driven by factors such as an ageing population, an increase in the incidence of chronic conditions such as diabetes and obesity, and increased knowledge of sophisticated wound care therapies. Dressings, wound treatment devices, and bioactive materials that promote wound healing through moisture management, tissue regeneration, and infection control are examples of advanced wound care solutions. As healthcare practitioners and patients seek better wound healing results, the advanced wound care market continues to experience substantial developments and R&D expenditures.

Increasing Incidence of Chronic Wounds drives the Advanced Wound Care Market growth.

The advanced wound care market is expanding due to the rising prevalence of chronic wounds worldwide. According to World Health Organisation research, chronic wounds such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers afflict millions of individuals, resulting in enormous healthcare costs. Diabetes prevalence, ageing populations, and lifestyle variables all lead to an increase in chronic wound cases. As a result, healthcare practitioners and patients are increasingly looking for enhanced wound care solutions that deliver quicker and more effective healing, fuelling demand for novel wound dressings, bioactive materials, and wound treatment devices. This trend is driving the growth of the advanced wound care market in order to meet the urgent demand for better wound treatment.

Growing Prevalence of Diabetes and Obesity Enhances the Advanced Wound Care Market Growth.

Because of the rising prevalence of diabetes and obesity worldwide, the advanced wound care market is expanding. According to the International Diabetes Federation, around 463 million individuals in 2019 had diabetes, with this figure expected to rise to 700 million by 2045. Diabetes and obesity are major risk factors for chronic sores including diabetic foot ulcers and pressure ulcers. As these illnesses worsen, there is a greater need for sophisticated wound care products and therapies that address the particular issues of wound management in diabetic and obese patients. Healthcare professionals are looking for novel wound dressings and bioactive solutions to enhance healing results and prevent problems in this vulnerable group, which is driving market expansion.

Technological Innovations in Bioactive Wound Care Products drive the Advanced Wound Care Market Growth.

Technological advancements in bioactive wound care products have revolutionised the advanced wound care market by giving efficient wound healing options. Bioactive wound care solutions interact with the wound environment to stimulate tissue regeneration. These revolutionary items include advanced dressings, growth hormones, and skin replacements. These technologies improve wound healing by creating a moist and favourable environment, lowering the risk of infection, and expediting tissue restoration. The development of bioactive wound care solutions provides healthcare clinicians and patients with a variety of choices for more effectively treating complicated wounds, chronic ulcers, and burns. As research and development in this discipline progresses, the market is likely to increase steadily, providing better patient outcomes and higher quality wound care.

North America is the Market Leader in the Advanced Wound Care Market.

North America dominates the advanced wound care market. A well-established healthcare system, a huge patient pool with chronic wounds, and an ageing population all contribute to the region's dominance. Furthermore, substantial R&D efforts, technical improvements, and increased healthcare expenditure all contribute to the advanced wound care market's growth in North America. Furthermore, the presence of important market participants, as well as a strong emphasis on novel wound care products and therapies, contribute to the region's leadership in this industry. The rising incidence of chronic illnesses including diabetes and obesity fuels demand for sophisticated wound care treatments in North America.

Growing Focus on Faster and Effective Wound Healing Bolsters the Advanced Wound Care Market Size.

The advanced wound care market is expanding due to a growing emphasis on quicker and more efficient wound healing. Healthcare practitioners and patients are looking for novel wound care solutions that help speed up healing and improve patient outcomes. The goal to shorten hospital stays, lower healthcare costs, and enhance patients' quality of life is driving the focus on speedier wound healing. To meet this need, advanced wound dressings, growth factors, and bioactive products are being developed, providing a favourable environment for tissue regeneration while reducing the risk of infection. As the need for speedy and effective wound healing becomes more widely recognised, the market is positioned for continued growth to satisfy these changing demands.

Key Developments:

• In July 2023, The worldwide medical technology company Smith+Nephew has announced the introduction of their REGENETEN Bioinductive Implant in India. The REGENETEN implant has had a dramatic influence on the way surgeons approach rotator cuff surgeries, with over 100,000 procedures conducted globally since its inception. The collagen-based REGENETEN Bioinductive Implant facilitates the creation of new tendon-like tissue1-3,6 to physiologically supplement the existing tendon and reverse the course of disease progression.
• In July 2023, Convatec Group Plc, an FTSE 100 global medical products and technologies company focused on chronic condition management announced a collaboration with Tandem Diabetes Care on a new five-inch infusion set for Tandem Mobi, the world's smallest durable automated insulin delivery system, which has now received FDA 510(k) clearance. Convatec is the global leader in the design and manufacture of infusion technology and insulin pump insertion devices. 

Company Products:

• Wound Dressings: Foam dressings, hydrocolloid dressings, and silicone dressings are among the advanced wound dressings available from Smith & Nephew. These dressings are intended to enhance successful wound healing by creating a moist wound-healing environment.
• Surgical Incision Management: The firm sells surgical incision management items such as sticky dressings and securement devices to help with post-operative wound care.
• Hydrocolloid Dressings: Mölnlycke offers hydrocolloid dressings that aid in autolytic debridement and wound healing.
• Silicone Dressings: Mölnlycke provides silicone-based wound dressings that are soft on the skin and cling well to uneven wound surfaces.
• Hydrofiber Dressings: ConvaTec provides hydrofiber dressings that absorb and seal away excess wound exudate, maintaining a moist wound-healing environment and improving wound healing.

Advanced Wound Care Market Scope:

 

Report Metric	Details
Market Size Value in 2021	US$3.133 billion
Market Size Value in 2028	US$4.27 billion
Growth Rate	CAGR of 4.52% from 2021 to 2028
Base Year	2021
Forecast Period	2023 – 2028
Forecast Unit (Value)	USD Billion
Segments Covered	Product Type, Wound Type, End-User, and Geography
Regions Covered	North America, South America, Europe, Middle East and Africa, Asia Pacific
Companies Covered	Smith & Nephew Plc, Acelity L.P. Inc. (Now Part Of 3m Company), Mölnlycke Health Care Ab (Now Part Of Investor Ab), Convatec Group Plc, Coloplast A/S, Integra Lifesciences Corporation, B. Braun Melsungen Ag, 3m Company, Paul Hartmann Ag, Medtronic Plc
Customization Scope	Free report customization with purchase

 

Segmentation:

• By Product Type
  • Dressings
    • Foam Dressings
    • Hydrocolloid Dressings
    • Alginate Dressings
    • Film Dressings
    • Hydrogel Dressings
    • Collagen Dressings
    • Others
  • Wound Therapy Devices
    • Negative Pressure Wound Therapy (Npwt) Devices
    • Oxygen And Hyperbaric Oxygen Equipment
    • Electrical Stimulation Devices
    • Ultrasound Therapy Devices
    • Others        
• By Wound Type
  • Diabetic Ulcers
  • Pressure Ulcers
  • Venous Ulcers
  • Surgical Wounds
  • Burns
  • Others                 
• By End-User
  • Hospitals And Clinics
  • Home Care Settings
  • Long-Term Care Centers
  • Ambulatory Surgical Centers
  • Others            
•  By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain    
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Taiwan
    • Others

1. INTRODUCTION

1.1. Market Overview

1.2. Market Definition

1.3. Scope of the Study

1.4. Market Segmentation

1.5. Currency

1.6. Assumptions

1.7. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY  

2.1. Research Data

2.2. Sources

2.3. Research Design

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4.. MARKET DYNAMICS

4.1. Market Drivers

4.2. Market Restraints

4.3. Porters Five Forces Analysis

4.3.1. Bargaining Power of Suppliers

4.3.2. Bargaining Power of Buyers

4.3.3. Threat of New Entrants

4.3.4. Threat of Substitutes

4.3.5. Competitive Rivalry in the Industry

4.4. Industry Value Chain Analysis

5. ADVANCED WOUND CARE MARKET, BY PRODUCT TYPE

5.1. Introduction

5.2. DRESSINGS 

5.2.1. FOAM DRESSINGS

5.2.2. HYDROCOLLOID DRESSINGS

5.2.3. ALGINATE DRESSINGS

5.2.4. FILM DRESSINGS

5.2.5. HYDROGEL DRESSINGS

5.2.6. COLLAGEN DRESSINGS

5.2.7. OTHERS 

5.3. WOUND THERAPY DEVICES

5.3.1. NEGATIVE PRESSURE WOUND THERAPY (NPWT) DEVICES

5.3.2. OXYGEN AND HYPERBARIC OXYGEN EQUIPMENT

5.3.3. ELECTRICAL STIMULATION DEVICES

5.3.4. ULTRASOUND THERAPY DEVICES

5.3.5. OTHERS        

6.  ADVANCED WOUND CARE MARKET, BY WOUND TYPE

6.1. Introduction

6.2. DIABETIC ULCERS

6.3. PRESSURE ULCERS

6.4. VENOUS ULCERS

6.5. SURGICAL WOUNDS

6.6. BURNS

6.7. OTHERS                 

7.  ADVANCED WOUND CARE MARKET, BY END-USER

7.1. Introduction

7.2. HOSPITALS AND CLINICS

7.3. HOME CARE SETTINGS

7.4. LONG-TERM CARE CENTERS

7.5. AMBULATORY SURGICAL CENTERS

7.6. OTHERS            

8.  ADVANCED WOUND CARE MARKET, BY GEOGRAPHY

8.1. Introduction

8.2. North America

8.2.1. United States

8.2.2. Canada

8.2.3. Mexico

8.3. South America

8.3.1. Brazil

8.3.2. Argentina

8.3.3. Others

8.4. Europe

8.4.1. United Kingdom

8.4.2. Germany

8.4.3. France

8.4.4. Italy

8.4.5. Spain

8.4.6. Others

8.5. Middle East and Africa

8.5.1. Saudi Arabia

8.5.2. UAE

8.5.3. Others

8.6. Asia Pacific

8.6.1. Japan

8.6.2. China

8.6.3. India

8.6.4. South Korea

8.6.5. Indonesia 

8.6.6. Taiwan

8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

9.1. Major Players and Strategy Analysis

9.2. Emerging Players and Market Lucrativeness

9.3. Mergers, Acquisitions, Agreements, and Collaborations

9.4. Vendor Competitiveness Matrix

10. COMPANY PROFILES

10.1. SMITH & NEPHEW PLC

10.2. ACELITY L.P. INC. (NOW PART OF 3M COMPANY)

10.3. MÖLNLYCKE HEALTH CARE AB (NOW PART OF INVESTOR AB)

10.4. CONVATEC GROUP PLC

10.5. COLOPLAST A/S

10.6. INTEGRA LIFESCIENCES CORPORATION

10.7. B. BRAUN MELSUNGEN AG

10.8. 3M COMPANY

10.9. PAUL HARTMANN AG

10.10. MEDTRONIC PLC     

Smith & Nephew Plc

Acelity L.P. Inc. (Now Part Of 3m Company)

Mölnlycke Health Care Ab (Now Part Of Investor Ab)

Convatec Group Plc

Coloplast A/S

Integra Lifesciences Corporation

B. Braun Melsungen Ag

3m Company

Paul Hartmann Ag

Medtronic Plc